Vanda Pharmaceuticals (VNDA) Other Non-Current Assets (2010 - 2015)
Vanda Pharmaceuticals (VNDA) posted Other Non-Current Assets of $813000.0 for Q3 2015, little changed sequentially from $813000.0 in Q2 2015, and up 3.57% YoY from $785000.0 in Q3 2014.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Other Non-Current Assets (2010 - 2015) Analysis & Trends
Vanda Pharmaceuticals has reported Other Non-Current Assets for 5 years, with the latest figure at $813000.0 in Q3 2015.
- Quarterly Other Non-Current Assets rose 3.57% year-over-year to $813000.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $813000.0 (up 3.57% YoY) and the FY2014 annual result came in at $813000.0, up 62.6% from the prior year.
- Other Non-Current Assets held at $813000.0 in Q3 2015 per VNDA's latest filing, from $813000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $1.0 million in Q3 2011 and troughed at $84000.0 in Q1 2012.
- A 5-year average of $682277.8 and a median of $692500.0 in 2011 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2012 and 2013: Other Non-Current Assets tumbled 41.75% in 2012, then soared 614.29% in 2013.
- Over 5 years, Other Non-Current Assets stood at $600000.0 in 2011, then changed by 0.0% to $600000.0 in 2012, then fell by 16.67% to $500000.0 in 2013, then soared by 62.6% to $813000.0 in 2014, then changed by 0.0% to $813000.0 in 2015.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $813000.0, $813000.0, and $813000.0 for Q3 2015, Q2 2015, and Q1 2015 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Vanda Pharmaceuticals | 327.03 Mn | 157.00 Mn | 46.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 813,000.00 |
| Jun 30, 2015 | 813,000.00 |
| Mar 31, 2015 | 813,000.00 |
| Dec 31, 2014 | 813,000.00 |
| Sep 30, 2014 | 785,000.00 |
| Jun 30, 2014 | 785,000.00 |
| Mar 31, 2014 | 785,000.00 |
| Dec 31, 2013 | 500,000.00 |
| Sep 30, 2013 | 500,000.00 |
| Jun 30, 2013 | 600,000.00 |
| Mar 31, 2013 | 600,000.00 |
| Dec 31, 2012 | 600,000.00 |
| Sep 30, 2012 | 600,000.00 |
| Jun 30, 2012 | 1.03 Mn |
| Mar 31, 2012 | 1.03 Mn |
| Dec 31, 2011 | 600,000.00 |
| Sep 30, 2011 | 1.03 Mn |
| Jun 30, 2011 | 530,000.00 |
| Dec 31, 2010 | 430,000.00 |